Press Releases about Incyte Corp
Incyte Gains Exclusive Global Development and Commercialization Rights to Tafasitamab (Monjuvi®)
February 05, 2024
From Incyte
Via Business Wire
Incyte to Report Fourth Quarter and Year-End 2023 Financial Results
January 23, 2024
From Incyte
Via Business Wire
Science Magazine Recognizes Incyte as #2 “Top Employer” of 2023
October 27, 2023
From Incyte
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.